A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndromeOliver Groß, Markus Feldkoetter, Kay Latta et al.|Kidney International|2020Cited by 151
Roifman Syndrome Is a Rare but Important Differential Diagnosis in Patients Suspected to Have CDG SyndromeI. Borgmann, Matthias Kettwig, Christin Johnsen et al.|Neuropediatrics|2023Cited by 0